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Abstract 
 
Because of the reported absence of demyelination in some animals with neurological signs of 
experimental allergic encephalomyelitis (EAE), it has been suggested that these signs are not due to 
demyelination. The present study demonstrates that there is ample demyelination in the central nervous 
system (CNS) and peripheral nervous system (PNS) to account for the neurological signs in rats with 
myelin basic protein (MBP)-induced acute EAE as well as in rats and rabbits with whole-spinal-cord-
induced acute EAE. The main reasons for failure to detect demyelination in animals with neurological 
signs of EAE appear to be inadequate histological techniques and incomplete examination of the 
nervous system, particularly the PNS and the lumbar, sacral and coccygeal segments of the spinal cord. 
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Introduction 
Experimental allergic encephalomyelitis (EAE), an autoimmune disease of the nervous system, is 
widely studied as an animal model of multiple sclerosis (MS), a human central nervous system 
(CNS) demyelinating disease of unknown aetiology (Raine 1984). The clinical status is the main 
guide to the progress of both EAE and MS, and the suppression of or improvement in the 
neurological signs of EAE by therapeutic agents (Alvord et al. 1965; Levine and Sowinski 1980) 
provides the basis for the use of these agents in MS. In MS, CNS demyelination contributes 
significantly to the production of neurological signs (McDonald 1974). However, because of 
reports of absent or minimal demyelination in some animals with neurological signs of acute EAE 
or the first attack of chronic relapsing EAE, it has been suggested that the signs of EAE are not due 
to demyelination (Hoffman et al. 1973; Lassmann and Wisniewski 1979; Panitch and Ciccone 
1981; Raine et al. 1981; Simmons et al. 1981, 1983; Kerlero de Rosbo et al. 1985). Furthermore, it 
has been stated that the recovery of function in rats with EAE is too rapid to be accounted for by 
remyelination, and that demyelination is therefore not responsible for the neurological signs 
(Panitch and Ciccone 1981; Simmons et al. 1981). There have even been reports of 
neurological signs of EAE in the absence of any demonstrable histological lesions of the 
nervous system (Paterson 1972, 1982). Thus the neurological signs of EAE have been 
attributed to oedema (Paterson 1976; Simmons et al. 1982, 1983) or an impairment of 
monoaminergic neurotransmission (Carnegie 1971; White 1984). 
It is clearly important to determine whether demyelination contributes to the 
production of neurological signs in EAE as it does in MS. This paper describes the 
histological findings in the CNS and the peripheral nervous system (PNS) of rabbits and rats 
with whole-spinal-cord-induced acute EAE and in rats with myelin basic protein (MBP)-
induced acute EAE. The involvement of the dorsal root ganglia (DRGs) in rabbits and rats 
with whole-spinal-cord-induced acute EAE has been previously reported (Pender and Sears 
1984, 1986). 
 
Materials and methods  
 
Animals 
Lewis rats, bred by the Animal Breeding Establishment of the John Curtin School of  
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Medical Research (JC strain) were kept in cages of five and fed rat and mouse cubes arid  
water ad libitum. New Zealand white male rabbits were obtained from one source, kept 
individually and fed rabbit-guinea pig pellets and water ad libitum. 
 
Induction of EAE 
 
(1) In rats (whole-spinal-cord-induced EAE). The inoculum was a homogenate of equal 
volumes of a 30% suspension of guinea pig spinal cord (the spinal roots having been 
removed) in 0.9% saline and a suspension of 4 mg of killed and dried Mycobacterium 
butyricum (Difco) per ml of incomplete Freund's adjuvant (Commonwealth Serum 
Laboratories, Melbourne, Australia). Under ether anaesthesia rats, 8-10 weeks old, were 
inoculated with 0.05 ml of inoculum in the footpad of each of the four feet. 
 
(2) In rats (MBP-induced EAE). MBP was prepared from guinea pig spinal cord (after 
removal of the spinal roots) by the method of Deibler et al. (1972). MBP in 0.9% saline was 
emulsified in an equal volume of incomplete Freund's adjuvant containing 4 mg/ml of 
added Mycobacterium butyricum. Rats, 8-10 weeks old, received 0.1 ml of emulsion in a 
footpad of each hindfoot. The total dose of MBP was 50 µg/rat. 
 
(3) In rabbits. Each batch of inoculum was prepared by mixing 5 g of rabbit spinal cord 
(the spinal roots having been stripped away) with 7 ml of incomplete Freund's adjuvant 
(Difco), 125 mg of H37 Ra heat-killed Mycobacterium tuberculosis (Difco) and 3 ml of 0.9% 
saline. Under sodium pentobarbitone anaesthesia, rabbits, 4-6 months old and weighing 2.5-
3.5 kg, were given intradermal injections of 0.1 ml of inoculum into each of four sites in the 
nuchal region. 
 
Histological studies 
Histological studies were performed on four rats (two male, two female) with whole-spinal-
cord-induced EAE, three male rats with MBP-induced EAE and seven rabbits with whole-
spinal-cord-induced EAE. These studies were done 2-3 days and 1-5 days after the onset of 
neurological signs in the rats and rabbits respectively. Two normal rats and two normal 
rabbits served as controls. The methods have been described in detail previously (Pender 
and Sears 1984, 1986; Pender 1985) and will be presented here briefly. Under ether 
anaesthesia the animals were perfused through the left ventricle with 0.9% saline followed 
by 2.5% (or 2%) glutaraldehyde/ 2% formaldehyde in 0.1 M sodium cacodylate buffer (pH 
7.3-7.4). In several rabbits 10% formol saline or formol calcium was used instead of 
glutaraldehyde/ formaldehyde. The brain, optic nerves, spinal cord, dorsal and ventral roots, 
dorsal root ganglia (DRGs), spinal nerves, sciatic and (rat) tail nerves were removed and 
immersed in fixative. Paraffin sections were stained with haematoxylin and eosin, luxol fast 
blue and cresyl fast violet, or chromoxane cyanin-R and neutral red. Rabbit tissues fixed 
with glutaraldehyde/ formaldehyde were post-fixed with 1% osmium tetroxide, embedded 
in Araldite, sectioned (0.5 µM) and stained with toluidine blue. Most of the rat tissues were 
post-fixed with 2% osmium tetroxide, embedded in HistoResin (LKB Bromma), sectioned 
(2 µm) and stained with toluidine blue in phosphate buffer (pH 7.6) or with cresyl violet. 
Some rat osmium-fixed tissues were embedded in Epok 812 (Ernest F. Fullam, 
Schenectady, NY). Semi-thin (1 µm) Epok 812 sections were stained with toluidine blue for 
light microscopy, and ultrathin sections were double-stained with uranyl acetate and lead 
citrate and examined in a Philips 301 electron microscope. 
 
Results 
 
Clinical findings 
In rats with whole-spinal-cord- or MBP-induced EAE, distal tail weakness commenced 8-14 
days after inoculation and was followed by flaccid tail paralysis, symmetrical hindlimb 
weakness and sometimes hindlimb paralysis. Forelimb weakness occurred occasionally. These 
signs were accompanied by weight loss. Most rats survived and by 20 days after inoculation 
were clinically normal apart from mild tail weakness. 
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Rabbits developed neurological signs 12-30 days after inoculation. The neurological 
signs were accompanied by weight loss and consisted of lateral splaying, ataxia and 
hypotonia of the hindlimbs and forelimbs, and loss of the knee jerks, followed by limb 
weakness, impairment of limb nociception, perineal soiling, paradoxical breathing and 
slowing of respiration (see Pender and Sears 1984). Some rabbits showed neurological 
improvement commencing 2-5 days after the onset of neurological signs. Such recovery was 
usually incomplete. 
 
Histological f indings 
 
(1) In rats. Both demyelination and inflammation were present in the brain-stem, spinal 
cord, DRGs, dorsal roots and ventral roots in all rats with MBP-induced EAE as well as in all 
rats with whole-spinal-cord-induced EAE (Figs. 1-5). The inflammatory infiltrate was 
predominantly mononuclear and was located in the meninges, in the subpial region and around 
blood vessels. Polymorphonuclear leukocytes and extravasated erythrocytes were often present 
in these lesions, particularly in MBP-induced EAE. Demyelination was much more readily 
detected in HistoResin and Epok 812 sections than in paraffin sections. Myelin debris was 
present in macrophages in some of the demyelinating lesions. Axons and neuronal cell bodies 
were generally preserved, although occasional degenerating axons were seen in the spinal 
roots and spinal cord, and in one animal there was damage to sacral motor neurone cell bodies 
in the vicinity of severe inflammation. Oedema was also present around some vessels in the 
CNS and PNS. Glial mitotic figures were often found in both the grey and white matter of the 
spinal cord. 
The spinal cord involvement increased caudally, the sacrococcygeal segments being the 
most severely affected. Lesions were present in the subpial and deep white matter (Figs. 1 and 
2) and also in the grey matter. Of the subpial regions, the ventral root exit zones and the dorsal 
root entry zones (Fig. 1) were most consistently affected. The ventral horns, dorsal horns and 
intermediate regions of the grey matter were frequently infiltrated with inflammatory cells. 
Demyelination was also present in the grey matter but was more difficult to recognize than in 
the white matter because of the presence of the normal unmyelinated dendrites. Intracellular 
myelin debris indicated demyelination in grey matter lesions. In contrast to the spinal cord and 
brainstem, the cerebral hemispheres were not involved. The cerebellum was mildly affected. 
In rats with whole-spinal-cord-induced EAE the DRG involvement increased caudally, it 
being very severe in the sacrococcygeal segments (see Pender and Sears 1986). However, in 
rats with MBP-induced EAE the DRG involvement did not increase caudally and was mild in 
all segments. In both whole-spinal-cord-induced EAE and MBP-induced EAE, demyelination 
was frequently present in the lumbar, sacral and coccygeal ventral and dorsal roots (Figs. 3 
and 4). Small diameter fibres were demyelinated as well as large ones. Diligent searching was 
not required to demonstrate demyelination. For example, in MBP-induced EAE, almost every 
examined 1-2 µm transverse section of individual dorsal or ventral roots showed at least some 
demyelinated fibres. The spinal nerves and the sciatic and tail nerves were either normal or 
minimally affected. 
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Fig. 1. Transverse sections through dorsal root entry zones of the S3 spinal cord segments of a normal 
control rat (A) and of a rat with whole-spinal-cord-induced EAE, 2 days after the onset of neurological signs 
(B). In the latter there are demyelinated axons in the PNS part of the dorsal root entry zone (small arrows) 
and also in the CNS part (large arrows). Epok 812 sections stained with toluidine blue. Bars = 25 µm. 
 
 
 
Journal of Neuroimmunology (1987) 15 (1): 11-24.                     http://dx.doi.org/10.1016/0165-5728(87)90003-8  
 
 
 
Fig. 2. Transverse section through a lateral funiculus of the L5 spinal cord segment of a rat with MBP-
induced EAE, 3 days after the onset of neurological signs. Demyelinated axons (small arrows) are present in 
perivascular (asterisk in vessel) and subpial regions of mononuclear infiltration (large arrow indicates 
surface of spinal cord). Epok 812 section stained with toluidine blue. Bar = 25 µm. 
 
Electron microscopy demonstrated primary demyelination of small and large diameter 
fibres with sparing of axons in rats with either type of EAE (Fig. 5). Macrophages containing 
myelin debris were often present within myelin sheaths. In the spinal cord and in the spinal 
roots there were occasional myelinated or demyelinated axons showing degenerative changes. 
Degenerating unmyelinated fibres were also occasionally seen. 
 
(2) In rabbits. Paraffin sections stained with haematoxylin and eosin showed meningeal 
and subpial infiltration and perivascular cuffing and infiltration with mononuclear leukocytes 
in the brainstem and spinal cord. In the PNS, similar perivascular lesions were found in the 
dorsal and ventral roots and particularly the DRGs. There was minimal if any involvement of 
the sciatic and spinal nerves. Some polymorphonuclear leukocytes were also present in the 
CNS and PNS inflammatory infiltrates. Paraffin sections stained with luxol fast blue and 
cresyl fast violet showed some demyelination in the regions of mononuclear infiltration but 
semi-thin Araldite sections were far superior for detecting this. Demyelination was most 
severe in the DRGs but was also present in the dorsal and ventral roots (Fig. 6) and in the 
spinal cord. In the spinal cord the demyelination was most evident in the subpial region, 
particularly the ventral root exit zones (Fig. 7) and dorsal root entry zones. In the regions of 
demyelination, axons were preserved and intracellular myelin debris was present within 
macrophages (Figs. 6 and 7). 
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Fig. 3. Transverse section through a L4 ventral root of a rat with MBP-induced EAE, 3 days after the onset 
of neurological signs. Many demyelinated axons are present (arrows). Myelin debris (arrowhead) can be 
seen within macrophages. HistoResin section stained with cresyl violet. Bar = 25 µm. 
 
Fig. 4. Transverse section through a S3 ventral root of a rat with MBP-induced EAE, 2 days after the 
onset of neurological signs. Demyelinated axons can be seen (arrows). Epok 812 section stained with 
toluidine blue. Bar = 25 µm.
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Fig. 5. Electron micrograph of the ventral root in Fig. 4. A demyelinated axon is seen (arrow). 
Bar = 2 µm. 
 
Fig. 6. Transverse section through a S1 ventral root of a rabbit with EAE, 5 days after the onset of 
neurological signs. There are many demyelinated axons (arrows). Myelin debris (arrowhead) can be 
seen, within macrophages. Araldite section stained with toluidine blue. Bar = 25 µm. 
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Fig. 7. Transverse section through a ventral root exit zone of the S1 spinal cord segment of a rabbit 
with EAE, 2 days after the onset of neurological signs. Mononuclear leukocytes infiltrate the meninges 
and the subpial region where they are associated with demyelination (arrows). Myelin debris 
(arrowhead) can be seen within macrophages. Araldite section stained with toluidine blue. Bar = 25 
µm. 
 
Discussion 
 
The present paper demonstrates that there is ample demyelination in the PNS and CNS to 
account for the neurological signs of MBP-induced EAE in rats as well as of whole-spinal-cord-
induced EAE in rats and rabbits. Other workers have also reported demyelination in these 
models (Waksman and Adams 1955; Wisniewski et al. 1969; Piliero and Cremonese 1973; 
McFarlin et al. 1974; Dal Canto et al. 1977). Electrophysiological studies have shown focal nerve 
conduction abnormalities in the DRGs and at the dorsal root entry zone in rabbits with EAE 
(Pender and Sears 1982, 1984, 1985), at the ventral root exit zones and in the DRGs of rats with 
whole-spinal-cordinduced EAE (Pender 1986a; Pender and Sears 1986) and in the 
sacrococcygeal dorsal roots of rats with MBP-induced EAE (Pender 1986b). As this localization 
of functional impairment corresponds with the localization of demyelination, it is likely that 
demyelination is the cause of the nerve conduction abnormalities. This conclusion is supported 
by the finding of the following characteristic pathophysiologic sequelae of demyelination: 
conduction slowing; conduction block; and the effects of temperature and the potassium channel 
blocking agent, 4-aminopyridine, on the conduction block. As inflammation is invariably 
present in the demyelinated regions, one could argue that an antibody or other product of the 
inflammatory response might cause the nerve conduction block by an action on the axonal 
membrane. If this were the case, conduction should also be blocked in  unmyelinated axons. 
However, we have shown that conduction is preserved in the unmyelinated axons of inflamed 
and demyelinated dorsal root ganglia, while it is severely impaired in demyelinated axons 
(Pender and Sears 1984). 
The ataxia in rabbits with EAE is accounted for by the demyelination-induced nerve 
conduction block of large diameter afferent fibres in the DRGs and dorsal root entry zones. 
The tail and hindlimb weakness in rats with EAE is readily explained by demyelination-
induced nerve conduction block of motor fibres in the ventral horn, between the ventral 
horn and the ventral root exit zone, in the ventral root exit zone itself and in the ventral  
Journal of Neuroimmunology (1987) 15 (1): 11-24.                     http://dx.doi.org/10.1016/0165-5728(87)90003-8  
 
 
roots. Demyelination of descending motor pathways in the brainstem and spinal cord and of  
the preterminal regions of fibres synapsing with ventral horn motoneurones may also 
contribute. The limb weakness in rabbits with EAE is likely to have a similar explanation. It 
should be noted that the functional effects of multiple demyelinating lesions scattered along 
the length of motor fibres from the ventral horn to the distal ventral root are cumulative, 
provided that different fibres are affected in each lesion. Demyelination can account for the 
neurological signs even if large demyelinating lesions are not present. As nerve conduction 
can be rapidly restored in demyelinated fibres before remyelination occurs (see below), the 
development of neurological signs in EAE is likely to be determined not only by the degree 
but also by the time course of demyelination. Slowly evolving asynchronous demyelination 
is much less likely to cause dysfunction than rapid simultaneous demyelination in the same 
number of fibres. 
The ascending progression of weakness, a characteristic feature of EAE in the rat 
(Williams and Moore 1973; Simmons et al. 1982), is at least partly accounted for by the 
caudally increasing length of the ventral roots. In a study on male albino rats, Waibl (1973) 
showed that the lengths of the spinal roots increase progressively from the first thoracic root 
(2 mm) to the third coccygeal root (59 mm). Thus the probability of many lesions in an 
entire ventral root increases progressively in a caudal direction. Therefore the probability 
of a high proportion of ventral root fibres undergoing demyelination-induced conduction 
block increases caudally. Simmons et al. (1982) have used a similar anatomically based 
explanation to account for the ascending weakness in rats with EAE but they attributed the 
weakness to oedema rather than to demyelination. The severe involvement of the 
sacrococcygeal segments of the spinal cord probably also contributes to the ascending 
pattern of weakness. In rats with EAE there is also an ascending impairment of tail 
nociception, which appears to be due to demyelination of small diameter afferent fibres in 
the sacrococcygeal DRGs, dorsal roots and dorsal root entry zones (Pender 1986b). 
Levine et al. (1975) reviewed reports of clinical signs without histological lesions of EAE. 
They concluded that these reports were invalid because of the nonspecificity of clinical signs, the 
occurrence of intercurrent diseases, the inadequacy or incorrect timing of histologic 
evaluations, and the lack of controls for specificity of the signs. The present paper emphasizes 
that, if clinicopathological correlations are to be made in EAE, one must thoroughly examine 
the PNS, which is known to be affected in EAE in all species studied (Freund et al. 1947; Ferraro 
and Roizin 1954; Waksman and Adams 1955, 1956; Levine and Wenk 1963; Wisniewski et al. 
1969; Piliero and Cremonese 1973; McFarlin et al. 1974; Dal Canto et al. 1977), as well as 
the CNS, particularly the lumbar, sacral and coccygeal segments of the spinal cord. The 
involvement of the PNS when animals are inoculated with whole CNS tissue or purified CNS 
MBP is explained by the fact that the P1 MBP from the PNS is similar, if not identical to, 
CNS MBP (Brostoff and Eylar 1972; Greenfield et al. 1973). Demyelination of the PNS may 
account for the occurrence of neurological signs in the absence of CNS demyelination in 
guinea pigs with bovine MBP-induced EAE or encephalitogenic peptide-induced EAE 
(Hoffman et al. 1973; Raine et al. 1981) and in guinea pigs during the acute phase of chronic 
relapsing EAE (Lassmann and Wisniewski 1979). When assessing the PNS in guinea pigs with 
EAE, particular attention should be given to the peripheral nerves themselves, as well as to 
the spinal roots and ganglia, because the peripheral nerves are particularly affected in this 
species (Waksman and Adams 1956). It should be noted that CNS demyelination does occur in 
MBP-induced EAE in guinea pigs when guinea pig MBP or higher doses of bovine MBP are 
used (Lampert and Kies 1967; Colover 1980; Moore et al. 1985). CNS demyelination also 
occurs in MBP-induced EAE in mice (Raine et al. 1984) and in monkeys (Alvord et al. 1980) 
as well as in rats (see above). The use of inadequate techniques probably often accounts for 
the failure to detect demyelination in EAE. To adequately assess demyelination, tissues 
should be fixed with glutaraldehyde and formaldehyde, post-fixed with osmium and 
embedded in a glycol methacrylate or epoxy resin. When HistoResin (LKB Bromma), a new 
glycol methacrylate-based embedding medium, is used, sections can be readily cut on a 
standard microtome and do not require the time, expertise and ultramicrotome needed to cut 
epoxy-resin-embedded material (Pender 1985). 
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It has been stated that the recovery of function in rats with EAE is too rapid to be 
accounted for by remyelination, and that demyelination is therefore not responsible for the 
neurological signs (Panitch and Ciccone 1981; Simmons et al. 1981). However, nerve  
conduction can be restored by the development of electrical excitability in demyelinated 
internodal axolemma as early as 4 days after the induction of demyelination by diphtheria 
toxin or lysophosphatidyl choline (Bostock and Sears 1978; Smith et al. 1982). Such a 
mechanism could readily account for the rapid recovery in rats with EAE. Rapid recovery 
could also be due to repair of structurally minor, yet functionally significant, damage to the 
myelin sheath, for example loosening of the paranodal axoglial junction (Hirano and 
Dembitzer 1978). In addition to demyelination, axonal degeneration may occur in EAE 
(Lampert and Kies 1967; Brown et al. 1982) and probably contributes to the persistent 
neurological deficits occurring in chronic EAE and to the neurological signs of hyperacute 
EAE. 
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